Hassan Gandjini

1.5k total citations
14 papers, 1.1k citations indexed

About

Hassan Gandjini is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Hassan Gandjini has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Hassan Gandjini's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pneumonia and Respiratory Infections (6 papers). Hassan Gandjini is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pneumonia and Respiratory Infections (6 papers). Hassan Gandjini collaborates with scholars based in France, Romania and United States. Hassan Gandjini's co-authors include Nathalie Dartois, Joan Korth‐Bradley, Gary Dukart, C. Angel Cooper, Julio A. Ramírez, Jean Li Yan, Paul C. McGovern, Philippe Gambert, Christian Lallemant and Anne Athias and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Hassan Gandjini

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hassan Gandjini France 10 506 374 356 187 180 14 1.1k
Jan Pachl Czechia 13 505 1.0× 412 1.1× 504 1.4× 227 1.2× 178 1.0× 23 1.4k
Luis M. Beltrán Spain 16 337 0.7× 135 0.4× 254 0.7× 139 0.7× 143 0.8× 50 1.1k
Athanasios Prekates Greece 16 319 0.6× 177 0.5× 293 0.8× 160 0.9× 142 0.8× 34 1.1k
Winnie Lee Singapore 19 464 0.9× 378 1.0× 251 0.7× 35 0.2× 108 0.6× 53 1.0k
Jiajun Liu United States 16 192 0.4× 427 1.1× 233 0.7× 34 0.2× 84 0.5× 41 1.0k
Gilbert M. Rose United States 10 532 1.1× 405 1.1× 198 0.6× 46 0.2× 70 0.4× 14 1.1k
J P Fillastre France 18 199 0.4× 477 1.3× 218 0.6× 100 0.5× 85 0.5× 75 1.0k
Oren Zusman Israel 16 371 0.7× 277 0.7× 280 0.8× 205 1.1× 130 0.7× 36 1.2k
Brenda Cirincione United States 17 310 0.6× 508 1.4× 160 0.4× 22 0.1× 189 1.1× 32 1.1k
Juan Antonio Márquez-Vácaro Spain 6 224 0.4× 145 0.4× 490 1.4× 72 0.4× 79 0.4× 6 878

Countries citing papers authored by Hassan Gandjini

Since Specialization
Citations

This map shows the geographic impact of Hassan Gandjini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Gandjini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Gandjini more than expected).

Fields of papers citing papers by Hassan Gandjini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Gandjini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Gandjini. The network helps show where Hassan Gandjini may publish in the future.

Co-authorship network of co-authors of Hassan Gandjini

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan Gandjini. A scholar is included among the top collaborators of Hassan Gandjini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan Gandjini. Hassan Gandjini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dartois, Nathalie, et al.. (2013). Tigecycline Versus Levofloxacin in Hospitalized PatientsWith Community-Acquired Pneumonia: An Analysis of Risk Factors. The Open Respiratory Medicine Journal. 7(1). 13–20. 4 indexed citations
2.
Ramírez, Julio A., Nathalie Dartois, Hassan Gandjini, et al.. (2013). Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 57(4). 1756–1762. 183 indexed citations
3.
Freire, Antonio, Min Ja Kim, Yin-Ching Chuang, et al.. (2010). Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagnostic Microbiology and Infectious Disease. 68(2). 140–151. 215 indexed citations
4.
Tănăseanu, Cristina, Slobodan Milutinović, Petre Iacob Calistru, et al.. (2009). Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. BMC Pulmonary Medicine. 9(1). 44–44. 40 indexed citations
5.
Tănăseanu, Cristina, Carlos Bergallo, Abel Jasovich, et al.. (2008). Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease. 61(3). 329–338. 93 indexed citations
6.
7.
8.
Dartois, Nathalie, et al.. (2008). Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia: European Experience. Journal of Chemotherapy. 20(sup1). 28–35. 29 indexed citations
9.
Gerbes, Alexander L., Veit Gülberg, Pere Ginès, et al.. (2003). Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial. Gastroenterology. 124(4). 933–939. 188 indexed citations
10.
Lagrost, Laurent, E Florentin, Valérie Guyard‐Dangremont, et al.. (1995). Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma. Arteriosclerosis Thrombosis and Vascular Biology. 15(9). 1388–1396. 55 indexed citations
11.
Gandjini, Hassan, et al.. (1995). Effect of Acute Glycerol Administration with or without a Mixed Meal in Humans. Annals of Nutrition and Metabolism. 39(2). 71–84. 4 indexed citations
12.
Gandjini, Hassan, Philippe Gambert, Anne Athias, et al.. (1994). Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns. Transfusion Science. 15(3). 289–297. 2 indexed citations
13.
Lagrost, Laurent, Hassan Gandjini, Anne Athias, et al.. (1993). Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(6). 815–825. 113 indexed citations
14.
Gandjini, Hassan, Philippe Gambert, Anne Athias, & Christian Lallemant. (1991). Resistance to LDL oxidative modifications of an N-terminal apolipoprotein B epitope. Atherosclerosis. 89(1). 83–93. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Pachl Breakdown of academic impact, for papers by Luis M. Beltrán Breakdown of academic impact, for papers by Athanasios Prekates Breakdown of academic impact, for papers by Winnie Lee Breakdown of academic impact, for papers by Jiajun Liu Breakdown of academic impact, for papers by Gilbert M. Rose Breakdown of academic impact, for papers by J P Fillastre Breakdown of academic impact, for papers by Oren Zusman Breakdown of academic impact, for papers by Brenda Cirincione Breakdown of academic impact, for papers by Juan Antonio Márquez-Vácaro
Rankless by CCL
2026